Teva, Boehringer Get Quick Appeal In Pay-For-Delay MDL
A Connecticut federal judge overseeing multidistrict litigation alleging Teva Pharmaceuticals USA Inc. and Boehringer Ingelheim Pharmaceuticals Inc. engaged in a pay-for-delay scheme over a generic version of stroke drug Aggrenox cleared...To view the full article, register now.
Already a subscriber? Click here to view full article